Duncker Streett & Co’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-122
Closed -$6.07K – 493
2023
Q4
$6.07K Hold
122
– – ﹤0.01% 430
2023
Q3
$6.54K Hold
122
– – ﹤0.01% 425
2023
Q2
$6.58K Hold
122
– – ﹤0.01% 421
2023
Q1
$6.64K Sell
122
-68
-36% -$3.31K ﹤0.01% 410
2022
Q4
$9.2K Buy
190
+122
+179% +$5.36K ﹤0.01% 416
2022
Q3
$3K Hold
68
– – ﹤0.01% 435
2022
Q2
$3K Hold
68
– – ﹤0.01% 443
2022
Q1
$3K Buy
+68
New +$3.51K ﹤0.01% 443
2013
Q3
– Sell
-600
Closed -$31K – 560
2013
Q2
$31K Buy
+600
New +$32K 0.01% 389

Other funds holding SNY

Duncker Streett & Co's SNY Position: Q1 2024 in Review

Duncker Streett & Co sold out of Sanofi (SNY) in Q1 2024, closing a stake of 122 shares — an estimated $6.07K sold.

Duncker Streett & Co first reported a position in SNY in Q2 2013 and held it in 9 quarters. The position peaked at $31K in Q2 2013. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

  • Duncker Streett & Co reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
  • Duncker Streett & Co sold 122 Sanofi shares in Q1 2024, an estimated $6.07K.
  • Duncker Streett & Co first reported a position in Sanofi in Q2 2013 and held it in 9 quarters.
  • Duncker Streett & Co's Sanofi position peaked at $31K in Q2 2013.
  • 713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Duncker Streett & Co's 13F filing for Q1 2024, filed 23 Apr 2024.